ADIPOQ and type 2 diabetes mellitus: Adiponectin has attracted considerable research attention because of its antidiabetes and anti-atherogenic effects and is expected to become a therapeutic target in the treatment of type 2 diabetes, metabolic syndrome, and cardiovascular diseases [12].